ArticleCancer gene therapy2021
ERK3/MAPK6 is required for KRAS-mediated NSCLC tumorigenesis.
Katarzyna Bogucka et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ArticleCancer gene therapy2021
Katarzyna Bogucka et al.PubMed ↗Publisher ↗
No numbers read from the abstract.